Stock AnalizGlobe Life Inc. GL
Life Insurance · data as of November 13, 2026
Globe Life Inc. (GL) is a financial company listed in the US with a market value of about $12.1B. In the twelve months to September 30, 2026 it had revenue of $6.3B and net income of $1.2B, a net margin of 18.9%.
Its overall Stock Analiz score is 3.6 out of 5 (good). The strongest part is value (5/5); the weakest is future growth (1/5).
Key numbers: a P/E of 10.7, a price to free cash flow of 9.1, 5-year revenue growth of 5% a year, a 5-year average ROIC of 19%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 21% above the current price.
Score: 3.6 / 5
Checks passed
- P/E below 25
- P/E below the industry median
- P/FCF below 20
- Price below intrinsic value (DCF, moderate assumptions)
- PEG below 1.5
- Profit margin improving
- 5-year EPS growth above 10% a year
- 5-year average ROIC above 12%
Checks not passed
- Revenue growth above 10% last year
- 3-year revenue growth above 10% a year
- 3-year free cash flow growth above 10% a year
- Strong R&D investment or growth above 20%
- 5-year revenue growth above 8% a year
- Interest covered more than 5 times
- Liabilities below 60% of assets
Valuation
Growth and quality
Financials, last 6 years
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | $6.3B | $6.0B | $5.8B | $5.4B | $5.2B | $5.1B | $4.7B |
| Net income | $1.2B | $1.2B | $1.1B | $971M | $894M | $1.0B | $732M |
| Free cash flow | $1.3B | $1.3B | $1.3B | $1.4B | $1.4B | $1.4B | $1.4B |
| EPS (diluted) | $14.96 | $14.07 | $11.94 | $10.07 | $9.04 | $9.99 | $6.82 |
| Net margin | 18.9% | 19.4% | 18.5% | 17.8% | 17.1% | 20.2% | 15.4% |
| ROIC | — | — | — | 15.6% | 16.0% | 24.6% | 6.9% |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
What analysts expect
The average 12-month price target from 11 analysts is $185.18, 15% above the current price; targets range from $161.00 to $215.00; the consensus rating is “none”; expected EPS is $15.49 for the fiscal year ending December 31, 2026.
Frequently asked questions
What is Globe Life’s P/E ratio?
About 10.7, based on the last twelve months of diluted earnings per share (forward P/E about 10.3).
Is Globe Life stock undervalued?
Our DCF model with moderate assumptions puts its intrinsic value about 21% above the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.
Does Globe Life pay a dividend?
Yes. The dividend yield is about 0.82%, and it has paid dividends for 6 years in our data.
Is Globe Life a good stock to buy?
We do not give buy or sell advice. Globe Life scores 3.6 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.